FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039878045> ?p ?o ?g. }

• W3039878045 endingPage "2122" @default.
• W3039878045 startingPage "2112" @default.
• W3039878045 abstract "Abstract Aims/hypothesis Approximately 10% of total healthcare budgets worldwide are spent on treating diabetes and its complications, and budgets are increasing globally because of ageing populations and more expensive second-line medications. The aims of the study were to estimate the within-trial and lifetime cost-effectiveness of the weight management programme, which achieved 46% remissions of type 2 diabetes at year 1 and 36% at year 2 in the Diabetes Remission Clinical Trial (DiRECT). Methods Within-trial analysis assessed costs of the Counterweight-Plus intervention in DiRECT (including training, programme materials, practitioner appointments and low-energy diet), along with glucose-lowering and antihypertensive medications, and all routine healthcare contacts. Lifetime cost per quality-adjusted life-year (QALY) was estimated according to projected durations of remissions, assuming continued relapse rates as seen in year 2 of DiRECT and consequent life expectancy, quality of life and healthcare costs. Results Mean total 2 year healthcare costs for the intervention and control groups were £3036 and £2420, respectively: an incremental cost of £616 (95% CI –£45, £1269). Intervention costs (£1411; 95% CI £1308, £1511) were partially offset by lower other healthcare costs (£796; 95% CI £150, £1465), including reduced oral glucose-lowering medications by £231 (95% CI £148, £314). Net remission at 2 years was 32.3% (95% CI 23.5%, 40.3%), and cost per remission achieved was £1907 (lower 95% CI: intervention dominates; upper 95% CI: £4212). Over a lifetime horizon, the intervention was modelled to achieve a mean 0.06 (95% CI 0.04, 0.09) QALY gain for the DiRECT population and mean total lifetime cost savings per participant of £1337 (95% CI £674, £2081), with the intervention becoming cost-saving within 6 years. Conclusions/interpretation Incorporating the lifetime healthcare cost savings due to periods of remission from diabetes and its complications, the DiRECT intervention is predicted to be both more effective (QALY gain) and cost-saving in adults with type 2 diabetes compared with standard care. This conclusion appears robust to various less favourable model scenarios, providing strong evidence that resources could be shifted cost-effectively to support achieving remissions with the DiRECT intervention. Trial registration ISRCTN03267836" @default.
• W3039878045 created "2020-07-10" @default.
• W3039878045 creator A5019479654 @default.
• W3039878045 creator A5037322796 @default.
• W3039878045 creator A5040022046 @default.
• W3039878045 creator A5050457617 @default.
• W3039878045 creator A5063602756 @default.
• W3039878045 creator A5064332338 @default.
• W3039878045 creator A5065094204 @default.
• W3039878045 creator A5072538572 @default.
• W3039878045 creator A5090271904 @default.
• W3039878045 date "2020-08-10" @default.
• W3039878045 modified "2023-10-12" @default.
• W3039878045 title "Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme" @default.
• W3039878045 cites W1524829680 @default.
• W3039878045 cites W2072455721 @default.
• W3039878045 cites W2097843889 @default.
• W3039878045 cites W2110791445 @default.
• W3039878045 cites W2122317738 @default.
• W3039878045 cites W2123974278 @default.
• W3039878045 cites W2126919962 @default.
• W3039878045 cites W2127283831 @default.
• W3039878045 cites W2282195952 @default.
• W3039878045 cites W2309974746 @default.
• W3039878045 cites W2338167986 @default.
• W3039878045 cites W2748764116 @default.
• W3039878045 cites W2765176640 @default.
• W3039878045 cites W2773791657 @default.
• W3039878045 cites W2785435636 @default.
• W3039878045 cites W2906199487 @default.
• W3039878045 cites W2919203803 @default.
• W3039878045 cites W2942135547 @default.
• W3039878045 cites W2945745351 @default.
• W3039878045 cites W2954934172 @default.
• W3039878045 cites W3092065440 @default.
• W3039878045 cites W4234995814 @default.
• W3039878045 doi "https://doi.org/10.1007/s00125-020-05224-2" @default.
• W3039878045 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7476973" @default.
• W3039878045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32776237" @default.
• W3039878045 hasPublicationYear "2020" @default.
• W3039878045 type Work @default.
• W3039878045 sameAs 3039878045 @default.
• W3039878045 citedByCount "26" @default.
• W3039878045 countsByYear W30398780452020 @default.
• W3039878045 countsByYear W30398780452021 @default.
• W3039878045 countsByYear W30398780452022 @default.
• W3039878045 countsByYear W30398780452023 @default.
• W3039878045 crossrefType "journal-article" @default.
• W3039878045 hasAuthorship W3039878045A5019479654 @default.
• W3039878045 hasAuthorship W3039878045A5037322796 @default.
• W3039878045 hasAuthorship W3039878045A5040022046 @default.
• W3039878045 hasAuthorship W3039878045A5050457617 @default.
• W3039878045 hasAuthorship W3039878045A5063602756 @default.
• W3039878045 hasAuthorship W3039878045A5064332338 @default.
• W3039878045 hasAuthorship W3039878045A5065094204 @default.
• W3039878045 hasAuthorship W3039878045A5072538572 @default.
• W3039878045 hasAuthorship W3039878045A5090271904 @default.
• W3039878045 hasBestOaLocation W30398780451 @default.
• W3039878045 hasConcept C112930515 @default.
• W3039878045 hasConcept C121955636 @default.
• W3039878045 hasConcept C126322002 @default.
• W3039878045 hasConcept C134018914 @default.
• W3039878045 hasConcept C144133560 @default.
• W3039878045 hasConcept C159110408 @default.
• W3039878045 hasConcept C160735492 @default.
• W3039878045 hasConcept C162324750 @default.
• W3039878045 hasConcept C168563851 @default.
• W3039878045 hasConcept C187212893 @default.
• W3039878045 hasConcept C2777180221 @default.
• W3039878045 hasConcept C2779951463 @default.
• W3039878045 hasConcept C3019080777 @default.
• W3039878045 hasConcept C50522688 @default.
• W3039878045 hasConcept C535046627 @default.
• W3039878045 hasConcept C555293320 @default.
• W3039878045 hasConcept C6964187 @default.
• W3039878045 hasConcept C71924100 @default.
• W3039878045 hasConceptScore W3039878045C112930515 @default.
• W3039878045 hasConceptScore W3039878045C121955636 @default.
• W3039878045 hasConceptScore W3039878045C126322002 @default.
• W3039878045 hasConceptScore W3039878045C134018914 @default.
• W3039878045 hasConceptScore W3039878045C144133560 @default.
• W3039878045 hasConceptScore W3039878045C159110408 @default.
• W3039878045 hasConceptScore W3039878045C160735492 @default.
• W3039878045 hasConceptScore W3039878045C162324750 @default.
• W3039878045 hasConceptScore W3039878045C168563851 @default.
• W3039878045 hasConceptScore W3039878045C187212893 @default.
• W3039878045 hasConceptScore W3039878045C2777180221 @default.
• W3039878045 hasConceptScore W3039878045C2779951463 @default.
• W3039878045 hasConceptScore W3039878045C3019080777 @default.
• W3039878045 hasConceptScore W3039878045C50522688 @default.
• W3039878045 hasConceptScore W3039878045C535046627 @default.
• W3039878045 hasConceptScore W3039878045C555293320 @default.
• W3039878045 hasConceptScore W3039878045C6964187 @default.
• W3039878045 hasConceptScore W3039878045C71924100 @default.
• W3039878045 hasFunder F4320320337 @default.
• W3039878045 hasIssue "10" @default.
• W3039878045 hasLocation W30398780451 @default.
• W3039878045 hasLocation W30398780452 @default.

• next